Validity and psychometric characteristics of the psoriatic arthritis quality of life (PSAQoL) questionnaire in the Turkish population
Rheumatology International · 2025
DOI: 10.1007/s00296-025-05911-6 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Rheumatology International, 2025. Verfasst von Mehmet Tuncay Duruöz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Division, Physical Medicine and Rehabilitation Department, Marmara University School of Medicine, Istanbul, Turkey. Hauptthemen laut MEDLINE: Quality of Life, Arthritis, Psoriatic. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Marmara University.
Abstract (Originalsprache)
The aim of this study was to translate and culturally validate the Psoriatic Arthritis Quality of Life Questionnaire (PsAQoL) into Turkish and to evaluate its reliability and validity in patients with psoriatic arthritis (PsA). A total of 162 PsA patients diagnosed according to CASPAR criteria were recruited from two rheumatology clinics. The PsAQoL was translated and culturally adapted into Turkish using a standardized forward-backward translation method. Internal consistency was assessed using Cronbach’s alpha. Construct validity was evaluated by correlating PsAQoL scores with quality of life (SF-36), functional (HAQ), emotional (HADS), and clinical disease activity indices (DAPSA, BASDAI, DAS28). The Turkish version of the PsAQoL was found to be clear, concise, and well understood by patients. The average time to complete the questionnaire was 3.3 ± 0.9 min. Internal consistency was good (Cronbach’s α = 0.930). Strong correlations were found with SF-36 physical ( r = − 0.744) and mental components ( r = − 0.731), indicating convergent validity. Moderate correlations were observed with HAQ ( r = 0.533), VAS pain ( r = 0.408), HADS-Anxiety ( r = 0.535), and HADS-Depression ( r = 0.517), while correlations with unrelated clinical parameters such as age and PASI were weak or insignificant, indicating divergent validity. No floor or ceiling effects were detected, and there were no missing responses. The Turkish version of the PsAQoL is a valid, reliable, and practical tool for assessing disease-specific quality of life in PsA. Its ease of use and psychometric strength support its application in both clinical practice and researchs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Rheumatology Division, Physical Medicine and Rehabilitation Department, Marmara University School of Medicine, Istanbul, Turkey.
- Physical Medicine and Rehabilitation Department, Sakarya University School of Medicine, Immunology Subdivision, Sakarya, Turkey.
- Rheumatology Division, Physical Medicine and Rehabilitation Department, Bahçeşehir University School of Medicine, Istanbul, Turkey.
- Physical Medicine and Rehabilitation, Sakarya Training and Research Hospital, Sakarya, Turkey.
- Rheumatology Division, Physical Medicine and Rehabilitation Department, Marmara University School of Medicine, Istanbul, Turkey. hande_snc@hotmail.com.
ORCID-Profile: Mehmet Tuncay Duruöz, Kemal Nas, Sevtap Acer Kasman, Emre Uzun, Halise Hande Gezer
Förderung
- Marmara University
Zitieren
APA
Duruöz, M. T., Nas, K., Acer Kasman, S., Uzun, E., & Gezer, H. H. (2025). Validity and psychometric characteristics of the psoriatic arthritis quality of life (PSAQoL) questionnaire in the Turkish population. Rheumatology International. https://doi.org/10.1007/s00296-025-05911-6
Vancouver
Duruöz MT, Nas K, Acer Kasman S, Uzun E, Gezer HH. Validity and psychometric characteristics of the psoriatic arthritis quality of life (PSAQoL) questionnaire in the Turkish population. Rheumatology International. 2025. doi:10.1007/s00296-025-05911-6
BibTeX
@article{Duruz2025,
author = {Duruöz, Mehmet Tuncay and Nas, Kemal and Acer Kasman, Sevtap and Uzun, Emre and Gezer, Halise Hande},
title = {Validity and psychometric characteristics of the psoriatic arthritis quality of life (PSAQoL) questionnaire in the Turkish population},
journal = {Rheumatology International},
year = {2025},
doi = {10.1007/s00296-025-05911-6}
}
EUVIMED